Jennifer L. Taubert - 15 Feb 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WWC. Innovative Medicine
Signature
/s/ Raavi K. Deol, as attorney-in-fact for Jennifer Taubert
Issuer symbol
JNJ
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
4
Filing time
20 Feb 2024, 17:58:17 UTC
Previous filing
15 Feb 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Award $0 +76,981 $0.000000 76,981 15 Feb 2024 Common Stock 76,981 $157.92 Direct F1
transaction JNJ Restricted Share Units Award $0 +4,782 $0.000000 4,782 15 Feb 2024 Common Stock 4,782 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F2 Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
F3 The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.